Catalytically inactive pseudophosphatases are able to signal in the absence of enzymatic activity. Analyzing the oocyte-to-zygote transition in the worm, Cheng et al. (2009) 
The pseudophosphatase STYX is an unusual putative phosphoserine/threonine/tyrosine binding protein, named purposefully with an allusion to the river of the underworld in Greek mythology (Wishart et al., 1995) . STYX displays the structural features of a dual-specificity protein tyrosine phosphatase (PTP) but lacks the critical nucleophilic Cys residue in the active site of these enzymes that is essential for activity. Consequently, it is catalytically dead. Many other pseudophosphatases have been identified (Tonks, 2006) . Furthermore, ~10% of the kinome encodes pseudokinases (Boudeau et al., 2006) , illustrating that such catalytically impaired proteins influence not only the dephosphorylation but also the phosphorylation side of signaling regulation. Two recent reports (Cheng et al., 2009; Parry et al., 2009 ) now reveal an important role for the pseudophosphatases EGG-4 and EGG-5 in controlling the oocyteto-zygote transition in Caenorhabditis elegans.
Introducing a single point mutation into STYX, to convert a Gly to a Cys at the active site, generates a catalytically functional enzyme (Wishart et al., 1995) , highlighting conservation of the PTP domain structure in the pseudophosphatase. Similarly, the membrane-distal D2 domains of transmembrane receptor-like PTPs are pseudophosphatases in which the PTP fold is preserved (Tonks, 2006) . What is the function of catalytically impaired proteins that look like a phosphatase? A structure-function analysis of PTP1B led to the discovery of "substrate trapping" mutant PTPs, which maintain a high affinity for substrate but do not catalyze dephosphorylation effectively (Flint et al., 1997) . This afforded a unique tool for identification of physiological substrates of PTPs. When expressed, this mutant binds to its physiological substrates in the cell, but because it is unable to dephosphorylate the targets efficiently, the mutant and substrates become locked in a stable complex, which can be isolated and the substrates identified (Blanchetot et al., 2005) . The success of this approach raises the question of whether there are physiological equivalents of such artificially generated pseudophosphatase "substrate trapping" mutants. The new studies from the Seydoux (Cheng et al., 2009) and Singson (Parry et al., 2009) labs published in Cell and Current Biology, respectively, reveal that the pseudophosphatases EGG-4 and EGG-5 trap the kinase MBK-2 during the oocyte-tozygote transition in C. elegans.
There are two stages to the oocyteto-zygote transition, oocyte maturation and egg activation. During maturation, the oocytes are released from cell-cycle arrest at prophase of the first meiotic division and progress to metaphase of the second meiotic division, where they arrest as an unfertilized egg. Egg activation, in response to sperm entry, triggers the completion of meiosis and the first mitotic division, culminating in zygote formation. The Cheng et al. (2009) and Parry et al. (2009) papers describe the regulation of an unusual dual-specificity tyrosine-regulated kinase (DYRK) called MBK-2 during this process. DYRKs undergo cotranslational autophosphorylation on Tyr residues in a YTY motif in the activation loop but phosphorylate Ser/Thr residues in target substrates and in so doing control cell cycle, growth, differentiation, and apoptosis (Yoshida, 2008) . In C. elegans, the DYRK homolog MBK-2 phosphorylates several critical substrates involved in the breakdown of microtubules, transcriptional silencing, and polarization of the zygote in the oocyte-to-zygote transition. The function of MBK-2/DYRK in this context is under tight control through proteinprotein interactions that regulate its activity and subcellular distribution. The pseudophosphatase EGG-3 is known to regulate MBK-2 function by controlling its access to substrates in the cytoplasm (Govindan and Greenstein, 2007) . EGG-3 interacts directly with MBK-2 to sequester this kinase in the cortex of the oocyte prior to meiosis. Then, at the beginning of meiosis, EGG-3 moves to the cytosol and is degraded, which releases MBK-2. Thus, the pseudophosphatase EGG-3 links the activity of MBK-2 to the transition of the oocyte through meiosis.
Cheng, Parry, and colleagues now report on two more pseudophosphatases, EGG-4 and EGG-5, that inhibit MBK-2 activity during oocyte maturation.
They display >99% sequence identity, and phylogenetic analysis illustrates that they are most closely related to the subfamily of dualspecificity phosphatases. The authors show that MBK-2 requires both EGG-3 and EGG-4/5 for its cortical localization prior to meiosis. EGG-4 and EGG-5 are largely redundant; however, loss of both causes MBK-2 to become cytosolic and leads to maternal effect lethality. Unlike EGG-3, which binds to the N terminus of the kinase, the pseudophosphatase domain of EGG-4/5 recognizes the YTY motif in the activation loop and inhib-its the ability of MBK-2 to phosphorylate the substrate MEI-1. Optimal binding of EGG-4/5 to MBK-2 occurs following autophosphorylation of the YTY motif; however, such phosphorylation is not essential for the interaction. The authors demonstrate that mutating the signature motif of EGG-4/5 to introduce further deviation from the consensus sequence of an active dual-specificity phosphatase impaired the interaction with MBK-2, consistent with an important role for the "active site" of the pseudophosphatase. However, they also show that inhibition of MBK-2 function by EGG-4/5 is not due to dephosphorylation resulting from any residual intrinsic phosphatase activity.
So how does the EGG-4/5 pseudophosphatase exert its effects on downstream signaling? EGG-4 inhibits the activity of MBK-2 in the absence of any other proteins in vitro. One possibility is that engagement of the activation loop of MBK-2 by the "active site" of EGG-4/5 is sufficient to force the kinase to adopt an inactive conformation. An alternative is suggested by the regulation of the insulin receptor by the adaptor protein GRB14. Here, the interaction between the SH2 domain of GRB14 and an autophosphorylation site on the receptor activation loop positions a distinct sequence from GRB14 so that it occupies the substratebinding site of the kinase (Depetris et al., 2005) . Perhaps binding of the pseudophosphatase domain to the YTY motif of MBK-2 positions a pseudosubstrate motif in EGG-4/5 so as to block the MBK-2 active site (Figure 1) . In either case, the direct interaction, rather than dephosphorylation, is inhibitory.
It has been suggested that catalytically inactive members of the PTP family may serve a "dominant-negative" function by physically blocking the access of native phosphatases and thereby protecting substrates from dephosphorylation. However, the use of the term "dominant-negative" may create a false impression. For example, a primary function of tyrosine phosphorylation is to generate docking sites for signaling molecules that possess pTyr-binding motifs, such as SH2 domains, leading to the assembly of multiprotein complexes. Dephosphorylation of these sites by an active phosphatase would impair interaction with SH2 domains. However, engagement of such sites by a "substrate trapping" pseudophosphatase would also present a physical barrier to complex formation. Therefore, rather than serving as a "dominant-negative" protein that blocks PTP function, such pseudophosphatases may actually exert a similar effect on signaling as the active PTP (Figure 1) . The advantages of pseudophosphatases over active enzymes in certain signaling contexts remain unclear, but perhaps further study of EGG-4/5 may provide new insights. It would be interesting to test whether, as in the case of STYX and the receptor PTPs, mutations could be introduced to generate a catalytically competent form of EGG-4/5 and to compare the effects of catalytically active and inactive forms of this protein on signaling by MBK-2.
